Method of administering amantadine prior to a sleep period

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8741343
SERIAL NO

12959321

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ADAMAS PHARMA, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Coffee, Michael Tiburon, US 29 491
Ganapati, Gangadhara Palo Alto, US 31 428
Katdare, Ashok Berkeley, US 29 443
Sathyan, Gayatri Bangalore, IN 39 659
Shek, Efraim Pleasanton, US 27 431
Vermani, Kavita Fremont, US 28 431
Went, Gregory T Mill Valley, US 126 3075

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00